| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | -0.096 | 0.008 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.008 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.1 | 0.008 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | 0.094 | 0.01 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.01 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | 0.092 | 0.02 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.02 |